1. Mild to moderate non-specific pain (pain score between 1 to 7) 2. Does it has any Adverse Effects after using Cannabis oil (Lung Dam Koh Tao formulation II) Pain,Cannabis oil,Adverse EffectsI,Cannabis oil (Lung Dam Koh Tao formulation II)
Conditions
Interventions
Patients experiencing mild to moderate pain associated with various medical conditions, such as cancer, palliative care patients, and individuals diagnosed with migraine.
Treatment
study group
Sponsors
Surat Thani Provincial Public Health Office
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients experiencing mild to moderate pain associated with various medical conditions, such as cancer, palliative care patients, and individuals diagnosed with migraine,2. Patients who have been diagnosed by a licensed modern medicine practitioner or a licensed Thai traditional medicine practitioner as requiring treatment with Lung Dam Koh Tao Cannabis Oil Formula 2,3. Patients without any of the following contraindications,Those with severe or unstable cardiopulmonary conditions, or who are at risk of cardiovascular disease,Patients with psychiatric disorders, Pregnant or breastfeeding women, Individuals with a known allergy to cannabis,Individuals with a history of substance abuse, including nicotine dependence or heavy alcohol consumption,Patients currently receiving anticoagulant therapy.
Exclusion criteria
Exclusion criteria: 1.Patients who experience severe adverse effects from the use of cannabis. 2.Patients who do not wish to continue participation in the study. 3.Patients who are unable to attend scheduled appointments or fail to return for follow-up evaluations with the Thai traditional medicine practitioner or applied Thai traditional medicine practitioner who prescribed the cannabis oil.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Day 0 (baseline), Day 7, and at 1, 3, and 6 months following the initial visit (Day 0) Likert scale,Adverse Effects Day 0 (baseline), Day 7, and at 1, 3, and 6 months following the initial visit (Day 0) Adverse Event Assessment Form | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality Of Life Day 0 (baseline), Day 7, and at 1, 3, and 6 months following the initial visit (Day 0) Edmonton Symptom Assessment System ,The 5-level EQ-5D version | — |
Countries
Thailand
Contacts
Public Contactnoppol vanichjaroen
Surat Thani Provincial Public Health Office
Outcome results
None listed